IGM Biosciences (Nasdaq: IGMS) is a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies. IgM antibodies have inherent properties that we believe may enable them to improve upon the efficacy and safety of IgG antibodies in multiple therapeutic application... Read more
Kura Oncology
22 followers
REVOLUTION Medicines
19 followers
SpringWorks Therapeutics
10 followers
BillionToOne
8 followers
Summit Therapeutics
8 followers
Kymera Therapeutics
7 followers
Immunovant
7 followers
Inari
7 followers
Dyne Therapeutics
6 followers
Beta Bionics
4 followers
Arcutis Biotherapeutics
3 followers
ADMA Biologics
3 followers